Compound information
- Natural Products
- ZC1123723
- Molecular Formula
- C16H19ClN2O5S
- Molecular Weight
- 386.070320388 g/mol
- Structure
-
- IUPAC Name
- [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxo-ethyl] (2E,4E)-hexa-2,4-dienoate
- InChI
- InChI=1S/C16H19ClN2O5S/c1-4-5-6-7-16(21)24-11-15(20)18-12-8-9-13(17)14(10-12)25(22,23)19(2)3/h4-10H,11H2,1-3H3,(H,18,20)/b5-4+,7-6+
- InChI Key
- LWYBBKAYQQIERJ-YTXTXJHMSA-N
- SMILES
- C/C=C/C=C/C(=O)OCC(=O)Nc1ccc(Cl)c(S(=O)(=O)N(C)C)c1
- Source
- ZINC000006513188
Warheads
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 92.78 Å2 | LogP | 2.639 |
LogS | -3.74 | LogD | 2.324 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.032 | Pgp substrate | 0.999 |
HIA | 0.976 | F20 % | 0.987 |
F30 % | 0.961 | Caco-2 | -4.848 |
MDCK | -5.364 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.008 | PPB | 98.955 |
VD | 0.475 | Fu | 1.415 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.025 | CYP1A2 substrate | 0.748 |
CYP2A6 substrate | 0.495 | CYP2B6 substrate | 0.546 |
CYP2C19 inhibitor | 0.06 | CYP2C19 substrate | 0.789 |
CYP2C8 substrate | 0.836 | CYP2C9 inhibitor | 0.279 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.06 |
CYP2D6 substrate | 0.798 | CYP2E1 substrate | 0.4 |
CYP3A4 inhibitor | 0.075 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.725 | CL | 10.277 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.024 | Hepatotoxicity | 0.964 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.012 |
FDAMDD | 0.459 | Skin Sensitization | 0.926 |
Carcinogenicity | 0.079 | Eye Corrosion | 0.003 |
Eye Irritation | 0.051 | Respiratory Toxicity | 0.839 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.489 | IGC50 | 3.329 |
LC50FM | 4.44 | LC50DM | 5.304 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.105 | NR-AR-LBD | 0.241 |
NR-AhR | 0.058 | NR-Aromatase | 0.179 |
NR-ER | 0.254 | NR-ER-LBD | 0.494 |
NR-PPAR-gamma | 0.778 | SR-ARE | 0.934 |
SR-ATAD5 | 0.438 | SR-HSE | 0.862 |
SR-MMP | 0.536 | SR-p53 | 0.343 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.